Streetbeat News

Stock Prices

EWT

TSM

The AI craze has significantly fueled the growth of Taiwan's ETF market, with a 77% increase in value from the previous year, raising concerns over market stability due to the rapid, potentially leveraged inflow of investments. Taiwan Semiconductor (NYSE:TSM) and the iShares MSCI Taiwan ETF (NYSE:EWT) are highlighted amidst this trend, with TSM's advancements and EWT's performance standing out. Analysts and regulators worry about the impact of geopolitical tensions and shifts in chip demand on this burgeoning market.

Portfolio Pulse from Benzinga Neuro

May 03, 2024 | 10:10 am

IMRN

Stephen Anastasiou has resigned from his position as Non-Executive Director of Immuron, effective immediately. Anastasiou, who has been a Director since 2013, played a significant role in the company's achievements, including the launch of Travelan® in the USA and Canada, and Immuron's dual listing on NASDAQ.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 10:06 am

CRBG

Corebridge Financial (NYSE:CRBG) reported Q1 2024 adjusted EPS of $1.10, surpassing the $1.05 estimate, and sales of $5.853B, exceeding the $5.440B estimate. This represents a 13.4% increase in earnings and a 9.14% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 10:05 am

CIO

City Office REIT has revised its FY24 Core FFO (Funds From Operations) per share outlook downwards from $1.18-$1.22 to $1.14-$1.18, compared to the estimated $1.20.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 10:05 am

JOUT

Johnson Outdoors reported Q2 earnings of $0.21 per share, missing the $0.50 estimate, and sales of $175.86M, beating the $158.76M estimate. Earnings decreased by 85.52% and sales by 12.99% from last year.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 10:04 am

AMRX

Amneal Pharmaceuticals (NYSE:AMRX) reported Q1 2024 adjusted EPS of $0.14, surpassing the $0.09 estimate, and sales of $659.191M, exceeding the $619.033M estimate. This represents a 16.67% increase in EPS and an 18.23% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 10:04 am

PRLB

Proto Labs (NYSE:PRLB) reported Q1 2024 adjusted EPS of $0.40, surpassing the $0.31 estimate, and sales of $127.890M, exceeding the $124.683M estimate. This represents a 33.33% increase in EPS and a 1.61% increase in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 10:03 am

CIO

City Office REIT (CIO) reported Q1 2024 Core FFO of $0.33 per share, surpassing the $0.31 estimate, with sales of $44.493M also beating the $43.355M estimate, despite a 3.19% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

May 03, 2024 | 10:02 am

FC

LZ

MG

NVEE

MISTRAS Group (NYSE:MG) reported Q1 earnings, surpassing estimates with an EPS of $0.07 against the expected $0.04, and revenue up $16.43 million YOY. The company's stock price saw a 2.19% increase the day after the announcement. Competitors Franklin Covey, NV5 Global, and LegalZoom.com also reported their earnings, with mixed results. Franklin Covey and LegalZoom.com exceeded EPS estimates, while NV5 Global fell short. Revenue performance varied among these companies, with MISTRAS Group and LegalZoom.com reporting positive surprises.

Portfolio Pulse from Benzinga Insights

May 03, 2024 | 10:00 am

AAPL

AMGN

STEM

Apple Inc. shares surged 6% in pre-market trading after announcing better-than-expected Q2 results, a $110-billion stock buyback program, and a dividend increase. Other stocks also moved significantly in pre-market trading, with notable gainers including Vaxxinity, El Pollo Loco, AXT, Inc., and Amgen Inc., each reporting positive financial results or corporate actions. Conversely, companies like NanoVibronix, Sprout Social, and Stem, Inc. saw declines due to disappointing financial results or corporate developments.

Portfolio Pulse from Avi Kapoor

May 03, 2024 | 9:57 am